Daewoong Pharmaceutical Revenue

Daewoong Pharmaceutical had revenue of 356.49B KRW in the quarter ending March 31, 2025, with 6.17% growth. This brings the company's revenue in the last twelve months to 1.44T, up 3.94% year-over-year. In the year 2024, Daewoong Pharmaceutical had annual revenue of 1.42T with 3.44% growth.

Revenue (ttm)

1,443.39B

Revenue Growth

+3.94%

P/S Ratio

1.28

Revenue / Employee

835.78M

Employees

1,727

Market Cap

1,847.91B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1,422.68B	47.35B	3.44%
Dec 31, 2023	1,375.33B	95.24B	7.44%
Dec 31, 2022	1,280.09B	127.12B	11.03%
Dec 31, 2021	1,152.98B	97.55B	9.24%
Dec 31, 2020	1,055.42B	-58.00B	-5.21%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,898.69B
Celltrion	3,662.23B
ALTEOGEN	151.65B
Yuhan	2,114.76B
SK Biopharmaceuticals	578.00B
HLB Co., Ltd.	74.64B
PharmaResearch	392.31B
LigaChem Biosciences	146.42B

Revenue Rankings

Daewoong Pharmaceutical News

2 months ago - Sun Pharma launches FEXUCLUE 40 mg in India for treatment of Erosive Esophagitis - Business Upturn

More News